TABLE 3.
Cleavage efficiency at the p28 and p65 sites, using polypeptides of increasing length as sources of PLP-1
| Enzymea | Length (amino acids)b | Mass (kDa)c | Cleavage efficiency (%)d
|
|
|---|---|---|---|---|
| pSPN1S1 | pSPΔMscN1S1 | |||
| SpeI | 294 | 31.9 | 0 | 1 |
| BstXI | 448 | 49.2 | 18 | 16 |
| NsiI | 638 | 69.3 | 33 | 29 |
| ClaI | 904 | 99.2 | 48 | 48 |
| AgeI | 1,161 | 128.0 | 100 | 100 |
To synthesize PLP-1-containing polypeptides, plasmid pCITE P1P2a (Fig. 1B) was linearized with the enzymes listed, followed by in vitro transcription-translation in the presence of 0.1 mM unlabeled methionine.
Lengths of polypeptides synthesized by using the truncated plasmid templates.
Predicted molecular mass of corresponding viral polypeptides.
Substrates were synthesized in similar reactions using [35S]methionine and either pSPN1S1 or pSPΔMscN1S1 as the template. Cleavage efficiency was calculated as described in Materials and Methods; the cleavage efficiency with the longest enzyme polypeptide was arbitrarily set to 100%.